CN101498730B - 一种改良的双抗原夹心免疫检测法 - Google Patents
一种改良的双抗原夹心免疫检测法 Download PDFInfo
- Publication number
- CN101498730B CN101498730B CN200910106053.0A CN200910106053A CN101498730B CN 101498730 B CN101498730 B CN 101498730B CN 200910106053 A CN200910106053 A CN 200910106053A CN 101498730 B CN101498730 B CN 101498730B
- Authority
- CN
- China
- Prior art keywords
- antigen
- antibody
- human igg
- sample
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000427 antigen Substances 0.000 title claims abstract description 94
- 238000001514 detection method Methods 0.000 title claims abstract description 45
- 230000036039 immunity Effects 0.000 title description 7
- 102000036639 antigens Human genes 0.000 claims abstract description 57
- 108091007433 antigens Proteins 0.000 claims abstract description 57
- 238000000034 method Methods 0.000 claims abstract description 55
- 102000004190 Enzymes Human genes 0.000 claims abstract description 21
- 108090000790 Enzymes Proteins 0.000 claims abstract description 21
- 238000012360 testing method Methods 0.000 claims description 64
- 239000007788 liquid Substances 0.000 claims description 23
- 238000002372 labelling Methods 0.000 claims description 18
- 238000007865 diluting Methods 0.000 claims description 13
- 238000003118 sandwich ELISA Methods 0.000 claims description 5
- 239000004816 latex Substances 0.000 claims description 4
- 229920000126 latex Polymers 0.000 claims description 4
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 229940005654 nitrite ion Drugs 0.000 claims description 2
- 238000003745 diagnosis Methods 0.000 abstract description 11
- 238000003018 immunoassay Methods 0.000 abstract description 9
- 238000006243 chemical reaction Methods 0.000 abstract description 8
- 239000000523 sample Substances 0.000 description 73
- 230000035945 sensitivity Effects 0.000 description 23
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 18
- 210000002966 serum Anatomy 0.000 description 18
- 239000010931 gold Substances 0.000 description 17
- 229910052737 gold Inorganic materials 0.000 description 17
- 238000010790 dilution Methods 0.000 description 16
- 239000012895 dilution Substances 0.000 description 16
- 239000000243 solution Substances 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 14
- 108090000623 proteins and genes Proteins 0.000 description 13
- 239000000463 material Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 241000589884 Treponema pallidum Species 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 10
- 239000011780 sodium chloride Substances 0.000 description 10
- 239000006228 supernatant Substances 0.000 description 10
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 9
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 8
- 230000009871 nonspecific binding Effects 0.000 description 8
- 239000013612 plasmid Substances 0.000 description 8
- 238000013016 damping Methods 0.000 description 7
- 239000012530 fluid Substances 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 241000711549 Hepacivirus C Species 0.000 description 6
- 239000000020 Nitrocellulose Substances 0.000 description 6
- 238000000502 dialysis Methods 0.000 description 6
- 229920001220 nitrocellulos Polymers 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 150000002460 imidazoles Chemical class 0.000 description 5
- 230000001900 immune effect Effects 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000007790 solid phase Substances 0.000 description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 4
- 235000011130 ammonium sulphate Nutrition 0.000 description 4
- 239000000084 colloidal system Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 210000003000 inclusion body Anatomy 0.000 description 4
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 4
- 239000012139 lysis buffer Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 238000002525 ultrasonication Methods 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- 238000009777 vacuum freeze-drying Methods 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229960001931 ampicillin sodium Drugs 0.000 description 3
- KLOHDWPABZXLGI-YWUHCJSESA-M ampicillin sodium Chemical compound [Na+].C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 KLOHDWPABZXLGI-YWUHCJSESA-M 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 3
- 239000012149 elution buffer Substances 0.000 description 3
- 239000003365 glass fiber Substances 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 230000032696 parturition Effects 0.000 description 3
- 238000003908 quality control method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229910021642 ultra pure water Inorganic materials 0.000 description 3
- 239000012498 ultrapure water Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000872931 Myoporum sandwicense Species 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 235000013877 carbamide Nutrition 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 239000002872 contrast media Substances 0.000 description 2
- -1 due to capillarity Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 238000003317 immunochromatography Methods 0.000 description 2
- 239000003547 immunosorbent Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- VOZKAJLKRJDJLL-UHFFFAOYSA-N 2,4-diaminotoluene Chemical compound CC1=CC=C(N)C=C1N VOZKAJLKRJDJLL-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 101710145634 Antigen 1 Proteins 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical class CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 1
- 241000594182 Sarcophaga sigma Species 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 229940021722 caseins Drugs 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000009137 competitive binding Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- FDWREHZXQUYJFJ-UHFFFAOYSA-M gold monochloride Chemical compound [Cl-].[Au+] FDWREHZXQUYJFJ-UHFFFAOYSA-M 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N hydrogen peroxide Substances OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 1
- 229960002064 kanamycin sulfate Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 238000013102 re-test Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- AYRVGWHSXIMRAB-UHFFFAOYSA-M sodium acetate trihydrate Chemical class O.O.O.[Na+].CC([O-])=O AYRVGWHSXIMRAB-UHFFFAOYSA-M 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910106053.0A CN101498730B (zh) | 2009-03-16 | 2009-03-16 | 一种改良的双抗原夹心免疫检测法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910106053.0A CN101498730B (zh) | 2009-03-16 | 2009-03-16 | 一种改良的双抗原夹心免疫检测法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101498730A CN101498730A (zh) | 2009-08-05 |
CN101498730B true CN101498730B (zh) | 2013-06-26 |
Family
ID=40945895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910106053.0A Active CN101498730B (zh) | 2009-03-16 | 2009-03-16 | 一种改良的双抗原夹心免疫检测法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101498730B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102062779A (zh) * | 2009-11-17 | 2011-05-18 | 上海荣盛生物药业有限公司 | 体外检测乙肝病毒c抗体的组合物 |
CN102023211B (zh) * | 2010-11-19 | 2014-02-12 | 广州万孚生物技术股份有限公司 | 一种全程定量检测c反应蛋白的免疫层析试纸条及其制备方法 |
CN102879584A (zh) * | 2012-09-26 | 2013-01-16 | 中国人民解放军军事医学科学院基础医学研究所 | 一种人血液hsp70抗体胶体金标检测试纸条及其制备方法 |
CN103983792B (zh) * | 2014-05-29 | 2015-09-30 | 同昕生物技术(北京)有限公司 | 一种免疫球蛋白侧向层析检测系统 |
CN109765363A (zh) * | 2019-01-25 | 2019-05-17 | 武汉璟泓万方堂医药科技股份有限公司 | 化学发光-免疫层析试纸及其检测方法 |
CN109991428A (zh) * | 2019-04-10 | 2019-07-09 | 成都博奥新景医学科技有限公司 | 一种经过封闭处理的双抗原夹心间接法 |
CN113252911B (zh) * | 2021-07-02 | 2021-12-10 | 珠海丽珠试剂股份有限公司 | SARS-CoV-2中和抗体的检测试剂盒及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1963519A (zh) * | 2005-11-10 | 2007-05-16 | 北京庄笛浩禾生物医学科技有限公司 | 一种a组轮状病毒抗原胶体金检测试纸条 |
CN101021532A (zh) * | 2007-03-28 | 2007-08-22 | 北京英诺特生物技术有限公司 | 联合检测特异性IgM、IgG抗体的胶体金层析条及其制备方法 |
-
2009
- 2009-03-16 CN CN200910106053.0A patent/CN101498730B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1963519A (zh) * | 2005-11-10 | 2007-05-16 | 北京庄笛浩禾生物医学科技有限公司 | 一种a组轮状病毒抗原胶体金检测试纸条 |
CN101021532A (zh) * | 2007-03-28 | 2007-08-22 | 北京英诺特生物技术有限公司 | 联合检测特异性IgM、IgG抗体的胶体金层析条及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101498730A (zh) | 2009-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101498730B (zh) | 一种改良的双抗原夹心免疫检测法 | |
CN101713779B (zh) | 一种用亲和素/链亲和素磁性复合微粒对生物分子进行免疫学检测的方法 | |
CN111733141B (zh) | 一种可分泌抗新型冠状病毒n蛋白单克隆抗体的杂交瘤细胞、单克隆抗体及应用 | |
EP2853894B1 (en) | Diagnostic kits and immunoassay methods for diagnosis and differentiation of African Swine Fever Virus (ASFV) and Classical Swine Fever Virus (CSFV) | |
CN111378018B (zh) | 一种检测新型冠状病毒抗体的试纸条及其制备方法和应用 | |
JP7060510B2 (ja) | 腫瘍マーカーの測定方法及び測定試薬 | |
US20230358757A1 (en) | Antigen for 2019 novel coronavirus and detection use thereof | |
CN105137072A (zh) | 一种结核分枝杆菌lam检测试剂盒、制备方法以及使用方法 | |
JPWO2015037635A1 (ja) | インフルエンザウイルスの免疫測定における検体処理方法及び免疫測定法 | |
Xie et al. | Preparation of highly specific monoclonal antibodies against SARS‐CoV‐2 nucleocapsid protein and the preliminary development of antigen detection test strips | |
CN111521804B (zh) | 一种处理剂及其应用 | |
CN103175963A (zh) | Tp抗体检测法及其检测试剂盒 | |
CN106841633B (zh) | 在荧光微球表面定向包被抗体的方法及其在糖化载脂蛋白a1检测中的用途 | |
CN108872608A (zh) | 一种用于检测犬瘟热病毒抗体的时间分辨荧光免疫试剂盒 | |
CN104677889A (zh) | 一种基于鲁米诺功能化的磁性免疫探针检测甲胎蛋白的方法 | |
CN102368068B (zh) | 检测肺炎衣原体IgM抗体的试剂盒 | |
CN111781353A (zh) | 检测SARS-CoV-2抗体的胶体金试纸条及其制备方法和应用 | |
Wu et al. | Simultaneous detection of multiple β-adrenergic agonists with 2-directional lateral flow strip platform | |
WO2023017817A1 (ja) | 免疫測定方法、検体希釈液、及びイムノクロマトグラフィーキット | |
CN109633163B (zh) | 降钙素原/c反应蛋白二合一检测试剂盒 | |
CN110954695A (zh) | 诺如病毒gi和gii型量子点联检试纸条及其制备方法和应用 | |
WO2022024925A1 (ja) | シグナルの低下を改善した検査試薬 | |
WO2022054821A1 (ja) | 偽陰性の抑制により特異性を改善した検査試薬 | |
CN114910647A (zh) | 细丝蛋白-A-IgG抗体在制备检测血管内皮损伤试剂盒中的应用 | |
CN114910650A (zh) | 检测抗膜突蛋白-IgG抗体的试剂在制备检测血管内皮损伤的试剂盒中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 518057 Guangdong city of Shenzhen province Nanshan District Xili liuxiandong Zhongshan Road No. 1001 TCL Science Park building D2 building 6 floor Applicant after: Shenzhen Feipeng Biological Co.,Ltd. Address before: 518054 Guangdong city of Shenzhen province Nanshan District Nanshan Road Nanyou fourth industrial district three building six floor East Applicant before: Shenzhen Feipeng Biological Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: FAPON BIOTECH CORP. Free format text: FORMER NAME: SHENZHEN FAPON BIOTECH INC. |
|
CP03 | Change of name, title or address |
Address after: 518000 Guangdong city of Shenzhen province Nanshan District Xili liuxiandong Zhongshan Road No. 1001 TCL Science Park building D2 building 6 floor Patentee after: FAPON BIOTECH Inc. Address before: 518057 Guangdong city of Shenzhen province Nanshan District Xili liuxiandong Zhongshan Road No. 1001 TCL Science Park building D2 building 6 floor Patentee before: Shenzhen Feipeng Biological Co.,Ltd. |
|
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Lin Yujia Inventor after: Pan Shaoli Inventor after: Hu Peng Inventor after: Peng Liang Inventor after: Yan Wenhao Inventor before: Yan Wenhao Inventor before: Pan Shaoli Inventor before: Hong Juan Inventor before: Peng Liang Inventor before: Wang Ningyan Inventor before: Wang Ronge Inventor before: Sun Xingbao Inventor before: Sun Jing Inventor before: Hu Peng |
|
COR | Change of bibliographic data | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170120 Address after: 518000 Guangdong city of Shenzhen province Nanshan District Xili liuxiandong Zhongshan Road No. 1001 TCL Science Park building D2 building 6 layer ABCD unit 601, 602, 603, 604. Patentee after: FAPON BIOTECH Inc. Patentee after: GUANGDONG FAPON BIOTECH Co.,Ltd. Address before: 518000 Guangdong city of Shenzhen province Nanshan District Xili liuxiandong Zhongshan Road No. 1001 TCL Science Park building D2 building 6 floor Patentee before: FAPON BIOTECH Inc. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 7 building, building 1, No. 5, Hualian Road, Songshan hi tech Industrial Development Zone, Dongguan, Guangdong, 523000 Co-patentee after: FAPON BIOTECH Inc. Patentee after: GUANGDONG FAPON BIOTECH Co.,Ltd. Address before: 518000 Guangdong city of Shenzhen province Nanshan District Xili liuxiandong Zhongshan Road No. 1001 TCL Science Park building D2 building 6 layer ABCD unit 601, 602, 603, 604. Co-patentee before: GUANGDONG FAPON BIOTECH Co.,Ltd. Patentee before: FAPON BIOTECH Inc. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210616 Address after: 523808 Room 403, building 1, No.1 Taoyuan Road, Songshanhu Park, Dongguan City, Guangdong Province Patentee after: Guangdong Weishi Biotechnology Co.,Ltd. Address before: 7 / F, No.1 Workshop, No.5 Hualian Road, Songshanhu high tech Industrial Development Zone, Dongguan City, Guangdong Province Patentee before: GUANGDONG FAPON BIOTECH Co.,Ltd. Patentee before: FAPON BIOTECH Inc. |